跳至主要内容
临床试验/NCT05008354
NCT05008354已完成4 期

Investigation of Pyridoxine Effect on Behavioral Adverse Events of Levetiracetam in Adult Patients With Epilepsy

Nasim Tabrizi1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Behavioral side effects

研究概览

简要总结

This study is a two-arm parallel group randomized double-blind placebo-controlled trial with the aim of Investigating pyridoxine effect on behavioral side effects of levetiracetam in adult patients with epilepsy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age≥18 years
  • Patients with epilepsy
  • Patients who are treated by levetiracetam (Levebel, Cobel darou) in recent month
  • Complaint of behavioral problem
  • Patient's consent for participation

排除标准

  • History of known psychiatric disease
  • Pregnancy
  • Incidence of psychotic side effects including hallucination, psychosis, suicidal idea or attempt
  • Treatment with psychiatric medications
  • Alcohol or drug abuse
  • Mental retardation to the degree that intervenes comprehension and response to questionnaire

研究组 & 干预措施

Pyridoxine

Active Comparator

干预措施: Pyridoxine (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Behavioral side effects

时间窗: 3 weeks

Behavioral side effects are measured by SCL-90-R questionnaire

次要结局

未报告次要终点

研究者

发起方
Nasim Tabrizi
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Nasim Tabrizi

Associate professor of neurology

Mazandaran University of Medical Sciences

研究点 (1)

Loading locations...

相似试验